Farmacología y Toxicología
Department
Baylor College of Medicine
Houston, Estados UnidosPublications in collaboration with researchers from Baylor College of Medicine (12)
2023
-
An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps
Cardiovascular Drugs and Therapy, Vol. 37, Núm. 6, pp. 1205-1223
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 353-370
-
Role of the Meningeal Lymphatics in Stroke
Stroke
-
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 6, pp. 570-582
2008
-
Aliskiren - The first of a new class of antihypertensive
Drugs in Context, Vol. 4, Núm. 1, pp. 105-120
-
Cervarix - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 59-70
-
Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups
Drugs in Context, Vol. 4, Núm. 1, pp. 71-84
-
Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia
Drugs in Context, Vol. 4, Núm. 1, pp. 85-104
-
Gardasil - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 29-40
-
Inegy - Effective combination treatment to target LDL-C levels
Drugs in Context, Vol. 4, Núm. 1, pp. 41-58
-
Telmisartan - An effective antihypertensive for 24-hour blood pressure control
Drugs in Context, Vol. 4, Núm. 1, pp. 1-14
-
Tiotropium - Advancing the treatment of COPD
Drugs in Context, Vol. 4, Núm. 1, pp. 15-28